000			01432 a2200337 4500
005			20250512222214.0
264		0	_c19830811
008			198308s 0 0 eng d
022			_a0027-8424
024	7		_a10.1073/pnas.80.13.4089 _2doi
040			_aNLM _beng _cNLM
100	1		_aGomez, C M
245	0	0	_aAnti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cJul 1983
300			_a4089-93 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcetylcholinesterase _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal
650	0	4	_aBungarotoxins _xmetabolism
650	0	4	_aChickens
650	0	4	_aDisease Models, Animal
650	0	4	_aMuscles _xdrug effects
650	0	4	_aMyasthenia Gravis _ximmunology
650	0	4	_aReceptors, Cholinergic _ximmunology
650	0	4	_aReceptors, Nicotinic
650	0	4	_aalpha7 Nicotinic Acetylcholine Receptor
700	1		_aRichman, D P
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 80 _gno. 13 _gp. 4089-93
856	4	0	_uhttps://doi.org/10.1073/pnas.80.13.4089 _zAvailable from publisher's website
999			_c6575229 _d6575229